Growth and Key Players in the Pharmaceutical CDMO Market: Opportunities and Trends
The global pharmaceutical Contract Development and Manufacturing Organization (CDMO) market was valued at $146.05 billion in 2023 and is expected to reach $315.08 billion by 2034, growing at a steady compound annual growth rate (CAGR) of 7.24% from 2024 to 2034.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5327
Pharmaceutical CDMO Market: A Key Partner for Pharma Companies
Pharmaceutical companies often face numerous challenges when researching and developing new therapeutic ingredients. The journey of bringing new drugs to market can be complex and costly. This is where partnering with a contract development and manufacturing organization (CDMO) becomes essential. By outsourcing manufacturing and development to a CDMO, pharma companies can access specialized expertise, save on costs, and scale production without investing heavily in infrastructure. Many companies rely on CDMOs to gain access to advanced technology, extra capacity, or specialized skills they lack in-house, ultimately reducing risk and streamlining the process.
Pharmaceutical CDMO Market Trends
In October 2024, Strides Pharma Science secured Rs 801 crore in equity during its pre-listing phase, attracting both domestic and international institutional investors to its affiliate company.
In June 2023, Saudi Arabia’s Public Investment Fund (PIF) launched Lifera, a new commercial-scale CDMO aimed at establishing Saudi Arabia as a global leader in pharmaceutical manufacturing. This initiative will strengthen national resilience and support the growth of the regional biotech and pharmaceutical sectors.
In March 2023, Pharmaron invested £151 million, backed by a UK Government grant, to expand its UK-based Gene Therapy CDMO. This expansion will increase its facilities by over 8,000 square meters to meet growing demand for viral vector and DNA production.
Market Opportunity: Personalized Medicine
Looking ahead, the pharmaceutical CDMO market is set to benefit from the growing demand for personalized medicine. Traditional manufacturing methods are not equipped to meet the specific needs of custom treatments. As a result, collaborating with a CDMO that specializes in small-scale, complex projects will be crucial. These organizations will play a vital role in delivering treatments that are safe, effective, and tailored to individual patient needs.
Top Players in the Pharmaceutical CDMO Market
- Veranova: Known for providing comprehensive services across the entire pharmaceutical development and manufacturing process.
- Sterling: A trusted partner specializing in drug development, manufacturing, and packaging.
- Fareva: A global contract manufacturer offering a wide range of services to pharmaceutical companies.
- Pfizer CentreOne: A division of Pfizer, providing a full suite of contract manufacturing services for the pharmaceutical sector.
- AjiBio: Focuses on offering high-quality manufacturing and development services for biopharmaceuticals.
- Uquifa: A key player in the manufacturing of active pharmaceutical ingredients (APIs) and advanced intermediates.
- Farmhispania: Specializes in the development and production of complex pharmaceutical products.
- Carbogen Amcis: Offers expertise in high-value manufacturing processes, particularly in the life sciences field.
- Evonik: Known for its advanced technologies in drug delivery systems and active pharmaceutical ingredient (API) production.
- FIS – Fabbrica Italiana Sintetici S.p.A.: Focuses on providing top-notch services in the development and production of APIs.
- Almac: A leading provider of integrated services for pharmaceutical companies, specializing in drug development and manufacturing.
- Dottikon: Offers tailored solutions for the manufacturing of APIs and other specialty products.
- Curia: A contract services provider that supports the development and commercialization of pharmaceutical products.
- CordenPharma International: Offers integrated services, from early-stage development to commercial-scale manufacturing.
- Piramal Pharma Solutions: A global leader in providing end-to-end solutions for pharmaceutical manufacturing.
- Samsung Biologics: Specializes in the development and manufacturing of biologic drugs.
- WuXi AppTec, Inc.: A prominent provider of services in the areas of drug discovery, development, and manufacturing.
- Siegfried Holding AG: Offers a range of services for the production of APIs and finished dosage forms.
- Cambrex Corporation: Provides comprehensive contract manufacturing services, specializing in the production of APIs and intermediates.
- Bushu Pharmaceuticals Ltd.: A key player in the production of APIs and drug development services.
- EuroAPI: Specializes in the production of APIs and offers services in regulatory compliance and quality assurance.
- Laboratory Corporation of America Holdings (LabCorp): Known for its broad range of services in the pharmaceutical and biotechnology industries.
- Sequens: A global leader in the development and manufacturing of pharmaceutical ingredients and intermediates.
- Hovione: Provides services ranging from drug development to commercial manufacturing, particularly in inhalation products.
- Nipro Corporation: A trusted partner for pharmaceutical and medical device companies, focusing on manufacturing and packaging services.
- Catalent, Inc.: Offers comprehensive services in drug development, delivery technologies, and commercialization.
- Thermo Fisher Scientific, Inc.: Known for its strong presence in the life sciences sector, providing manufacturing and development solutions.
- Recipharm AB: A leading contract manufacturer that focuses on the production of complex drug forms.
- Axplora: A rising name in pharmaceutical development, providing flexible and customized solutions.
- Lonza: One of the largest and most respected names in the CDMO sector, offering services in biologics and pharmaceuticals.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/pharmaceutical-cdmo-market-sizing
Access exclusive insight now @ https://www.towardshealthcare.com/price/5327
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
